Clinical Trials Directory

Trials / Completed

CompletedNCT06567405

Derma Pen as Treatment of Gingivitis Induced by Orthodontics

Impact of Derma Pen in the Treatment of Gingivitis Induced by Orthodontic Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Safa Basiouny Alawy · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Not accepted

Summary

Although orthodontic therapy frequently improves tooth alignment and appearance, its problems with oral hygiene can make patients highly susceptible to gingivitis. After orthodontic treatment, gingivitis is a typical problem. New treatments that promote healing and decrease inflammation are needed. Ascorbic acid and Derma Pen used together have recently surfaced as a potentially effective therapy option for patients who seeking for periodontal therapy during and after orthodontic treatments.

Conditions

Interventions

TypeNameDescription
PROCEDUREmechanical periodontal treatmentPatients will undergo subgingival scaling employing a Piezoelectric ultrasonic scaler to eliminate local factors.
DEVICEDerma pen with topical ascorbic Acidlocal anesthesia of 2% lignocaine will be administered by infiltration technique in the anterior maxillary region. Microneedling of the mucosa will be performed using dermapen needles, employing an intermittent back-and-forth motion in the anterior maxillary and mandibular region for 30-40 seconds, reaching a depth of 1.5 mm. This will involve the creation of microholes in the gingival tissue using derma pen to enhance the concentration and penetration of the ascorbic Acid through the gingival tissues.

Timeline

Start date
2024-05-30
Primary completion
2024-12-01
Completion
2025-02-07
First posted
2024-08-22
Last updated
2025-05-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06567405. Inclusion in this directory is not an endorsement.